What this trial studies
Potential Therapeutic Implications of laser Acupoints on Visceral Fat and Hormonal Changes in Post-menopausal Women
Conditions in scope
- Post-menopausal Women
- Visceral Fat
Interventions
- Potential Therapeutic Implications of laser Acupoints on Visceral Fat and Hormonal Changes in Post-menopausal Women (Other) — Application of laser acupuncture ( E M E ) on 10 acupuncture procedure for each woman which will be detected by therapist according to Acupuncture points Will stimulate St 25 (Tianshu), St 36 (Zusanli), Liv 3 (Taichong); P 6 (Neiguan),…
Who can join
Women only · Ages 50 Years to 65 Years · Accepts healthy volunteers.
Inclusion criteria
- Post-menopausal women
- Woman with visceral obesity
- with age ranges from 50-65years
- Body mass index (BMI) more than 30 kg/m2
- WHR more than 0.8
Exclusion criteria
- Endometrial cancer
- Insulin resistance
- Or metabolic disorders
- Diabetes
- Hypertensive •NOT receiving any medication of obesity
Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.
Where it’s happening
| City | State / Region | Facility | Site status |
|---|---|---|---|
| Cairo | US | Nawal Reda Rashad Mohamed | Unknown |
Status & timeline
- Overall status: Completed
- Study type: Interventional
- Phase: N/A
- Start date: 2024-07-01
- Primary completion: 2024-09-01
- Last update posted: 2024-11-22
- First posted: 2024-11-22
Sponsor & contact
Lead sponsor: Kafrelsheikh University (Other)
For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.
Outcome measures
Primary outcomes
- Potential Therapeutic Implications of laser Acupoints on Visceral Fat and Hormonal Changes in Post-menopausal Women (for 8 weeks)
measured in both group before and after treatment. To get in touch with the hunger and satiety cues,BMI ,WHR and serum insulin level. - Body Mass Index (BMI) (for 8 weeks)
The weight in kg
Related ClearedRx care
If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.
Important. Information from ClinicalTrials.gov as of May 8, 2026. Trial details (status, sites, contacts, eligibility, outcomes) change frequently — always check the official record at https://clinicaltrials.gov/study/NCT06702358 before contacting a site.
ClearedRx is not affiliated with this trial or its sponsor. We index public-domain ClinicalTrials.gov records to help patients find evidence-based context for menopause care decisions. ClearedRx itself is a telehealth menopause/HRT brand — we do not enroll patients in trials.